Skip to main content
. 2020 May 26;1(1):286–292. doi: 10.1002/jha2.20

TABLE 3.

CMV reactivation following haplo‐BMT

PT‐CY/BEN PT‐CY P
CMV status recipient/donor, n (%)
R+/D+ 1/4 (25) 3/4(75) .49
R+/D− 0/4 (0) 2/2 (100) .06
R−/D+ 0/0 (0) 0/1 (50) .99
Total/at risk 1/8 (12.5) 5/7 (71.4) .04
R−/D− 0/1(0) 0/1 (0)